Thomas P. Mathers, Chief Executive Officer at CoLucid Pharmaceuticals, Inc. (CLCD), sold 1,502 shares at $28.57 ($43K) on 2016-11-07, disclosed to the SEC on 2016-11-07.
Scheduled sale ($43k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CLCD | SELL | 2016-10-05 | $111K | — | Filing → |
| CLCD | SELL | 2016-09-16 | $140K | — | Filing → |
| CLCD | SELL | 2016-09-07 | $201K | — | Filing → |